diabet
mellitu
metabol
endocrin
disord
character
hyperglycemia
lead
alter
carbohydr
lipid
protein
metabol
associ
absolut
rel
defici
insulin
secret
andor
insulin
action
valiathan
million
peopl
worldwid
diabet
number
like
doubl
world
health
organ
manag
diabet
insulin
synthet
oral
hypoglycem
drug
biguanid
sulfonylurea
metformin
produc
seriou
side
effect
addit
fail
prevent
diabetesrel
complic
mani
patient
new
diabet
manag
strategi
need
effect
lessen
side
effect
prabhar
dobl
regard
sever
speci
plant
plantbas
compound
describ
scientif
literatur
hypoglycem
activ
due
perceiv
effect
minim
side
effect
rel
low
cost
de
sousa
et
al
theaflavin
major
chemic
constitu
black
tea
report
antioxid
almajano
gordon
anticanc
gosslau
et
al
antiinflammatori
zu
et
al
antimicrobi
almajano
et
al
friedman
antivir
abil
includ
bovin
coronaviru
bovin
rotaviru
clark
et
al
liu
et
al
yang
et
al
influenza
zu
et
al
cantator
randal
traum
adam
howev
protect
effect
theaflavin
glycoprotein
compon
tca
cycl
enzym
highfat
diet
streptozotocininduc
diabet
rat
explor
far
therefor
present
studi
aim
evalu
effect
theaflavin
glycoprotein
compon
tca
cycl
enzym
diabet
rat
structur
theaflavin
given
fig
theaflavin
streptozotocin
highfat
diet
compon
cholesterol
bile
salt
egg
yolk
power
lard
obtain
sigma
chemic
compani
st
loui
mo
usa
sisco
research
laboratori
pvt
ltd
mumbai
india
central
drug
hous
pvt
ltd
new
delhi
india
skm
egg
product
export
india
limit
erod
tamil
nadu
india
lard
obtain
local
market
chennai
chemic
use
analyt
grade
male
albino
wistar
rat
weigh
g
bodi
weight
procur
central
anim
hous
facil
univers
madra
taramani
campu
chennai
tamil
nadu
india
maintain
ambient
temperatur
lightdark
cycl
anim
given
standard
commerci
rat
chow
water
ad
libitum
hous
standard
environment
condit
throughout
studi
experi
conduct
accord
institut
anim
ethic
committe
guidelin
iaec
anim
divid
seven
group
six
anim
rat
fed
highfat
diet
consist
standard
laboratori
chow
lard
yolk
powder
cholesterol
bile
salt
week
xie
et
al
week
anim
kept
overnight
fast
inject
low
dose
streptozotocin
mgkg
dissolv
sodium
citrat
buffer
ph
wu
et
al
fast
blood
glucos
measur
day
inject
rat
fast
blood
glucos
level
mgdl
consid
diabet
diabet
rat
fed
highfat
diet
anoth
week
experi
total
rat
diabet
surviv
rat
normal
rat
divid
seven
group
six
rat
eachgroup
normal
control
receiv
ml
distil
water
group
ii
drug
control
normal
healthi
control
rat
receiv
intragastr
theaflavin
mgkg
bwt
dissolv
ml
distil
water
daysgroup
iii
diabet
controlgroup
iv
diabet
rat
receiv
intra
gastric
theaflavin
mgkg
bwt
dissolv
ml
distil
water
daysgroup
v
diabet
rat
receiv
intra
gastric
theaflavin
mgkg
bwt
dissolv
ml
distil
water
daysgroup
vi
diabet
rat
receiv
intra
gastric
theaflavin
mgkg
bwt
dissolv
ml
distil
water
daysgroup
vii
diabet
rat
receiv
intra
gastric
metformin
mgkg
bwt
dissolv
ml
distil
water
day
day
treatment
anim
depriv
food
overnight
sacrif
decapit
blood
collect
two
differ
tube
ie
one
mixtur
potassium
oxal
sodium
fluorid
estim
plasma
insulin
glucos
glycoprotein
anoth
ethylen
diamin
tetra
acet
acid
edta
estim
hemoglobin
glycat
hemoglobin
liver
kidney
tissu
excis
immedi
rins
icechil
normal
salin
remov
blood
known
weight
tissu
minc
homogen
ml
buffer
ph
ice
cold
condit
homogen
centrifug
supernat
use
estim
variou
biochem
paramet
section
pancrea
kept
asid
histolog
studi
plasma
glucos
estim
method
trinder
use
reagent
kit
trinder
hemoglobin
hb
glycat
hemoglobin
estim
method
drabkin
austin
sudhakar
pattabiraman
respect
plasma
insulin
measur
method
burgi
briner
franken
kessler
glycoprotein
compon
hexos
hexosamin
fucos
sialic
acid
estim
method
disch
shettl
duboi
gill
wagner
warren
respect
tca
cycl
enzym
isocitr
dehydrogenas
dehydrogenas
succin
dehydrogenas
malat
dehydrogenas
assay
method
bell
baron
mehler
kornberg
grisolia
ochoa
reed
mukherje
slater
bonner
respect
protein
content
plasma
tissu
homogen
estim
method
lowri
rosebrough
farr
randal
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
mathrm
homa
mathrm
ir
mathrm
fast
mathrm
insulin
time
mathrm
fast
mathrm
blood
mathrm
sugar
end
document
blood
pancreat
tissu
test
rat
fix
formaldehyd
dri
evalu
arrang
ethanol
embed
paraffin
liver
section
thick
acquir
util
rotari
microtom
afterward
rehydr
section
stain
hematoxylineosin
h
e
view
light
microscop
shot
photomicrographi
data
analyz
student
softwar
hypothesi
test
method
includ
oneway
analysi
varianc
anova
follow
lsd
valu
mean
three
replic
valu
express
mean
sd
result
consid
statist
signific
p
valu
less
blood
glucos
plasma
insulin
level
normal
experiment
rat
given
tabl
diabet
rat
show
signific
increas
blood
glucos
signific
decreas
plasma
insulin
level
administr
theaflavin
dose
diabet
rat
caus
signific
decreas
blood
glucos
level
signific
increas
plasma
insulin
compar
diabet
untreat
rat
context
diabet
rat
show
signific
increas
homair
compar
control
rat
supplement
theaflavin
significantli
decreas
homair
index
dosedepend
manner
theaflavin
dose
mgkg
bodi
weight
show
highli
signific
effect
two
dose
mgkg
bwt
effect
compar
metformin
therefor
mgkg
bodi
weight
fix
effect
dose
use
analysi
level
hemoglobin
control
experiment
anim
depict
tabl
diabet
rat
show
signific
decreas
level
total
hemoglobin
signific
increas
level
compar
control
rat
level
total
hemoglobin
significantli
revers
administr
theaflavin
metformin
diabet
rat
normal
rat
treat
theaflavin
dose
mgkg
bodi
weight
show
signific
chang
plasma
glucos
insulin
hemoglobin
level
level
plasma
tissu
glycoprotein
hexos
hexosamin
fucos
sialic
acid
present
tabl
significantli
elev
level
glycoprotein
observ
plasma
tissu
diabet
control
rat
compar
normal
rat
howev
administr
theaflavin
metformin
diabet
rat
period
day
result
signific
reduct
hexos
hexosamin
fucos
sialic
acid
plasma
compar
diabet
control
rat
level
sialic
acid
significantli
decreas
wherea
level
hexos
hexosamin
fucos
significantli
increas
tissu
diabet
rat
administr
theaflavin
metformin
diabet
rat
significantli
revers
chang
tissu
near
normal
level
tabl
repres
activ
tca
cycl
key
enzym
liver
kidney
tissu
control
experiment
rat
liver
kidney
tissu
diabet
rat
show
signific
decreas
activ
isocitr
dehydrogenas
dehydrogenas
succin
dehydrogenas
malat
dehydrogenas
diminish
activ
key
enzym
revert
close
normalci
treatment
theaflavin
metformin
diabet
rat
figur
repres
hematoxylin
eosin
stain
pancrea
control
experiment
rat
normal
histolog
featur
exocrin
endocrin
part
shown
section
pancreat
tissu
control
rat
fig
pancreat
section
theaflavinalon
treat
rat
show
chang
beta
cell
look
like
control
pancrea
fig
section
pancreat
tissu
diabet
rat
show
degen
chang
islet
character
reduct
number
size
islet
subsequ
central
area
pancreat
islet
complet
empti
compar
control
rat
fig
section
pancreat
tissu
diabet
rat
treat
theaflavin
metformin
show
mark
regener
islet
signific
number
granul
cell
diabet
rat
moreov
sever
islet
well
granul
compar
pancreat
islet
diabet
rat
indic
improv
function
cell
reflect
increas
plasma
insulin
level
fig
e
metabol
disord
glucos
import
fundament
patholog
chang
diabet
blood
glucos
level
key
indic
evalu
success
model
effect
drug
experiment
result
show
drug
significantli
reduc
high
blood
sugar
regul
glycogen
synthesi
signific
maintain
normal
blood
sugar
improv
glucos
toler
henc
blood
glucos
key
marker
diagnosi
prognosi
diabet
mellitu
insulin
defici
caus
radic
elev
level
blood
glucos
result
excess
product
endogen
glucos
hepat
well
extrahepat
tissu
gluconeogen
glycogenolyt
pathway
reduc
consumpt
glucos
glycolyt
tca
cycl
glycogen
hmp
shunt
pathway
variou
tissu
diabet
mellitu
sole
kleinek
moreov
insulin
defici
high
level
plasma
glucos
diabet
condit
may
result
increas
synthesi
oligosaccharid
moieti
glycoprotein
hexos
hexosamin
fucos
sialic
acid
import
role
mainten
structur
integr
membran
bilay
cell
surfac
glycoprotein
vital
role
transport
vitamin
lipid
signal
transduct
hormon
receptor
immunolog
specif
present
studi
upon
treatment
theaflavin
metformin
appreci
lower
level
blood
glucos
improv
insulin
highfat
diet
streptozotocininduc
diabet
rat
glucos
lower
elev
insulin
level
brought
antioxid
potenti
theaflavin
almajano
et
al
consumpt
natur
antioxid
phytochem
report
potenti
health
benefit
help
regener
cell
protect
pancreat
islet
cytotox
effect
streptozotocin
alvarez
et
al
rangkadilok
et
al
glycosyl
hemoglobin
clinic
marker
chronic
glycem
control
patient
diabet
mellitu
koenig
et
al
persist
hyperglycemia
lead
glycosyl
amino
group
lysin
residu
protein
asgari
naderi
sarrafzadegan
condit
favor
reduct
level
total
hemoglobin
elev
glycosyl
hemoglobin
turn
directli
proport
blood
glucos
alyassin
ibrahim
diabet
rat
show
higher
level
glycosyl
hemoglobin
indic
poor
glycem
control
oral
administr
theaflavin
metformin
diabet
rat
significantli
reduc
level
compar
untreat
diabet
rat
reflect
antioxid
potenti
theaflavin
metformin
longterm
control
hyperglycemia
insulin
secret
function
glycoprotein
stabil
tissu
may
involv
maintain
structur
stabil
collagen
fibril
glycoprotein
import
compon
intracellular
matrix
cell
membran
membran
subcellular
organel
zachariah
basu
diabet
synthesi
glycoprotein
decreas
reduc
incorpor
glucos
caus
insulin
defici
increas
glycosyl
variou
protein
diabet
patient
also
report
earlier
elev
glycoprotein
diabet
may
also
predictor
angiopath
complic
konukoglu
serin
akcay
hatemi
rahman
zafar
shera
studi
observ
alter
level
hexos
hexosamin
fucos
sialic
acid
plasma
tissu
streptozotocin
highfat
dietinduc
diabet
rat
theaflavin
metformin
administr
diabet
rat
normal
level
glycoprotein
plasma
tissu
decreas
hyperglycem
state
increas
level
plasma
insulin
observ
theaflavin
metformintr
diabet
rat
might
respons
benefici
chang
glycoprotein
plasma
liver
kidney
context
research
shown
decreas
hyperglycemia
could
lead
decreas
glycoprotein
level
gandhi
chowdhuri
latha
pari
sundaram
naresh
shanthi
sachdanandam
mitochondria
play
part
regul
divers
physiolog
function
provid
energi
major
intracellular
process
necessari
vital
function
mitochondria
one
key
cell
organel
diabet
research
central
role
regul
energi
balanc
wallac
magnet
reson
spectroscopi
studi
human
suggest
subtl
defect
mitochondri
function
might
take
part
pathogenesi
insulin
resist
diabet
widespread
metabol
diseas
world
lowel
shulman
present
studi
activ
mitochondri
marker
dehydrogenas
dehydrogenas
succin
dehydrogenas
malat
dehydrogenas
significantli
drop
liver
kidney
highfat
diet
streptozotocininduc
diabet
rat
result
agreement
previou
report
akud
et
al
sener
rasschaert
malaiss
howev
diabet
rat
treat
theaflavin
metformin
result
signific
mark
elev
activ
tca
cycl
enzym
might
due
normoglycem
potenti
theaflavin
metformin
popul
cell
islet
langerhan
pancrea
reflect
product
secret
insulin
present
studi
histopatholog
find
reveal
sever
necrot
chang
pancreat
islet
rel
small
number
insulinposit
cell
observ
highfat
diet
streptozotocininduc
diabet
rat
evid
possibl
assum
theaflavin
treatment
might
stimul
insulin
secret
exist
cell
base
result
obtain
conclud
oral
administr
theaflavin
diabet
rat
restor
alter
glycoprotein
compon
tca
cycl
enzym
near
normal
level
correct
hyperglycemia
find
suggest
theaflavin
complimentari
potenc
develop
antihyperglycem
agent
treatment
diabet
mellitu
studi
progress
elicit
exact
mechan
antihyperglycem
action
theaflavin
diabet
